ROLE OF BLOOD PRESSURE REDUCTION IN PREVENTION OF CARDIAC AND VASCULAR HYPERTROPHY
We investigated whether prevention of cardiac and vascular remodelling associated with inhibition of angiotensin II is independent of the blood pressure (BP) lowering action of angiotensin II type 1 (AT1) receptor blockade. Spontaneously hypertensive rats, 8 weeks old, were treated with olmesartan,...
Saved in:
| Main Authors: | H. Yokoyama, D. B. Averill, K. B. Brosnihan, R. D. Smith, E. L. Schiffrin, C. M. Ferrario |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2011-08-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/1131 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reversal of vascular hypertrophy in hypertensive patients through blockade of angiotensin II receptors
by: R. D. Smith, et al.
Published: (2010-12-01) -
Carotid intima-media thickness and plaque volume changes following 2-year angiotensin II-receptor blockade. The Multicentre Olmesartan atherosclerosis Regression Evaluation (MORE) study
by: Kl. O. Stumpe, et al.
Published: (1970-01-01) -
Stellate Ganglionectomy Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction
by: Hui Yan, et al.
Published: (2025-02-01) -
Psychosomatic status and myocardial hypertrophy remodelling specificity
by: G. A. Usenko, et al.
Published: (2018-12-01) -
Protein phosphatases in pathological cardiac hypertrophy
by: ZHANG Xutao, et al.
Published: (2024-04-01)